DNM1L and neoplasm: Importantly, an advanced clinical stage of the tumor (TNM > 2) was significantly associated with a high level of p-Drp1 (Ser616; P = 0.0002, Supplementary Fig. 2a), but clinical stage was not associated with the level of p-Drp1 (Ser637; Supplementary Fig. 2b).